Kestra Private Wealth Services LLC Trims Stock Position in The Clorox Company (NYSE:CLX)

Kestra Private Wealth Services LLC trimmed its position in The Clorox Company (NYSE:CLX) by 31.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,870 shares of the company’s stock after selling 4,158 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in Clorox were worth $1,265,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Choreo LLC grew its position in Clorox by 12.8% in the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock worth $819,000 after acquiring an additional 652 shares during the period. abrdn plc grew its holdings in shares of Clorox by 20.1% during the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after purchasing an additional 33,135 shares during the period. International Assets Investment Management LLC increased its position in shares of Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after purchasing an additional 481,725 shares during the last quarter. Adage Capital Partners GP L.L.C. purchased a new stake in Clorox in the 3rd quarter valued at about $6,605,000. Finally, Eagle Rock Investment Company LLC acquired a new position in Clorox in the fourth quarter valued at about $2,940,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 1.0 %

Shares of NYSE:CLX opened at $138.23 on Friday. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $176.24. The company’s 50 day moving average is $148.74 and its two-hundred day moving average is $143.08. The company has a market cap of $17.17 billion, a PE ratio of 71.62, a P/E/G ratio of 2.08 and a beta of 0.44. The company has a current ratio of 0.90, a quick ratio of 0.57 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. Clorox’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.51 earnings per share. Equities analysts predict that The Clorox Company will post 5.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.47%. Clorox’s dividend payout ratio is presently 248.70%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on CLX shares. Barclays dropped their price target on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a research report on Thursday. The Goldman Sachs Group initiated coverage on Clorox in a research report on Friday, March 1st. They issued a “sell” rating and a $140.00 target price on the stock. Evercore ISI lowered their price target on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday. DA Davidson reaffirmed a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a research note on Wednesday, April 17th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research note on Wednesday, April 17th. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $146.43.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.